ConductScience.org, home

Paper32091066

Moderate cooling coprecipitation for extremely small iron oxide as a pH dependent T1-MRI contrast agent.

Chen B and 13 others. Nanoscale, 2020. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Moderate cooling coprecipitation for extremely small iron oxide as a pH dependent T1-MRI contrast agent. Papers, record 32091066. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32091066

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Moderate cooling coprecipitation for extremely small iron oxide as a pH dependent T1-MRI contrast agent.
PubMed
Journal
Nanoscale
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
1.33
iCite
Revised in PubMed
2020-10-14
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen BBo
2Guo ZZhanhang
3Guo CChunxian
4Mao YYu
5Qin ZZhiguo
6Ye DDewen
7Zang FFengchao
8Lou ZZhichao
9Zhang ZZuoheng
10Li MMingyue
11Liu YYanlong
12Ji MMin
13Sun JJianfei
14Gu NNing

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Contrast MediaMajor topic
Ferric CompoundsMajor topic
Magnetic Resonance ImagingMajor topic
Animals
Brain
Cell Survival
Ferrosoferric Oxide
Hydrogen-Ion Concentration
Mesenchymal Stem Cells
Nanoparticles
Particle Size
Rats
Temperature

Source PubMed

Download CSV of topics

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
41343885Superparamagnetic iron oxide nanoparticles in clinical applications: current status and future perspectives.EBioMedicine2025https://conductscience.org/library/papers/41343885PubMed
40284493Applications and Efficacy of Iron Oxide Nanoparticles in the Treatment of Brain Tumors.Pharmaceutics2025https://conductscience.org/library/papers/40284493PubMed
39791792Iron Oxide Nanoparticle-Based T1 Contrast Agents for Magnetic Resonance Imaging: A Review.Nanomaterials (Basel)2024https://conductscience.org/library/papers/39791792PubMed
38633040Ultrasmall Mn-doped iron oxide nanoparticles with dual hepatobiliary and renal clearances for T1 MR liver imaging.Nanoscale Adv2024https://conductscience.org/library/papers/38633040PubMed
36902163Cellular 1H MR Relaxation Times in Healthy and Cancer Three-Dimensional (3D) Breast Cell Culture.Int J Mol Sci2023https://conductscience.org/library/papers/36902163PubMed
34239302Neurite Extension and Orientation of Spiral Ganglion Neurons Can Be Directed by Superparamagnetic Iron Oxide Nanoparticles in a Magnetic Field.Int J Nanomedicine2021https://conductscience.org/library/papers/34239302PubMed
34093865Improving the sensitivity of T1 contrast-enhanced MRI and sensitive diagnosing tumors with ultralow doses of MnO octahedrons.Theranostics2021https://conductscience.org/library/papers/34093865PubMed
32517085Magnetic Nanomaterials as Contrast Agents for MRI.Materials (Basel)2020https://conductscience.org/library/papers/32517085PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32091066

GET https://conductscience.org/api/papers/v1/32091066/authors